ASX - By Stock
|
RNU |
Re:
Ann: Major Capacity Upgrade for Siviour
|
|
Kelly 42
|
552 |
164K |
4 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
552
|
164K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
Kelly 42
|
60 |
29K |
0 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
60
|
29K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
Kelly 42
|
60 |
29K |
0 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
60
|
29K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
Kelly 42
|
60 |
29K |
2 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
60
|
29K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
Kelly 42
|
60 |
29K |
0 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
60
|
29K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
Kelly 42
|
60 |
29K |
2 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
60
|
29K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Change of Registered Office and Principal Place of Business
|
|
Kelly 42
|
7 |
5.9K |
3 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
7
|
5.9K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil Investor Update
|
|
Kelly 42
|
23 |
12K |
1 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
23
|
12K
|
1
|
|
ASX - By Stock
|
CRL |
Re:
Ann: COMET RAISES $1M IN STRATEGIC INVESTOR PLACEMENT
|
|
Kelly 42
|
90 |
17K |
4 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
90
|
17K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil FY21 half yearly review
|
|
Kelly 42
|
34 |
19K |
0 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
34
|
19K
|
0
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
Kelly 42
|
2.1K |
635K |
3 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
2.1K
|
635K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: 2020 AGM CEO Presentation
|
|
Kelly 42
|
7 |
3.2K |
10 |
20/10/20 |
20/10/20 |
ASX - By Stock
|
7
|
3.2K
|
10
|
|
ASX - By Stock
|
ICI |
Re:
Ann: Suspension from Official Quotation
|
|
Kelly 42
|
33 |
17K |
3 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
33
|
17K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update
|
|
Kelly 42
|
95 |
39K |
3 |
12/09/20 |
12/09/20 |
ASX - By Stock
|
95
|
39K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update
|
|
Kelly 42
|
95 |
39K |
14 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
95
|
39K
|
14
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update
|
|
Kelly 42
|
95 |
39K |
5 |
06/09/20 |
06/09/20 |
ASX - By Stock
|
95
|
39K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update
|
|
Kelly 42
|
95 |
39K |
3 |
06/09/20 |
06/09/20 |
ASX - By Stock
|
95
|
39K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update
|
|
Kelly 42
|
95 |
39K |
2 |
05/09/20 |
05/09/20 |
ASX - By Stock
|
95
|
39K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update
|
|
Kelly 42
|
95 |
39K |
2 |
05/09/20 |
05/09/20 |
ASX - By Stock
|
95
|
39K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update - Conference Call Notification
|
|
Kelly 42
|
26 |
8.8K |
0 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
26
|
8.8K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update - Conference Call Notification
|
|
Kelly 42
|
26 |
8.8K |
0 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
26
|
8.8K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update - Conference Call Notification
|
|
Kelly 42
|
26 |
8.8K |
0 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
26
|
8.8K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update - Conference Call Notification
|
|
Kelly 42
|
26 |
8.8K |
0 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
26
|
8.8K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update
|
|
Kelly 42
|
95 |
39K |
5 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
95
|
39K
|
5
|
|
ASX - By Stock
|
AQX |
Re:
AQX chart
|
|
Kelly 42
|
213 |
70K |
1 |
30/08/20 |
30/08/20 |
ASX - By Stock
|
213
|
70K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update
|
|
Kelly 42
|
95 |
39K |
6 |
30/08/20 |
30/08/20 |
ASX - By Stock
|
95
|
39K
|
6
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update
|
|
Kelly 42
|
95 |
39K |
5 |
30/08/20 |
30/08/20 |
ASX - By Stock
|
95
|
39K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update
|
|
Kelly 42
|
95 |
39K |
6 |
29/08/20 |
29/08/20 |
ASX - By Stock
|
95
|
39K
|
6
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Files For Registration Of Oncosiltm Device In U.S. Market
|
|
Kelly 42
|
28 |
10K |
2 |
09/08/20 |
09/08/20 |
ASX - By Stock
|
28
|
10K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Files For Registration Of Oncosiltm Device In U.S. Market
|
|
Kelly 42
|
28 |
10K |
2 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
28
|
10K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil presents clinical data at ESMO World Congress
|
|
Kelly 42
|
12 |
4.3K |
1 |
03/07/20 |
03/07/20 |
ASX - By Stock
|
12
|
4.3K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Investor Presentation
|
|
Kelly 42
|
126 |
49K |
0 |
24/06/20 |
24/06/20 |
ASX - By Stock
|
126
|
49K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Investor Presentation
|
|
Kelly 42
|
126 |
49K |
6 |
14/06/20 |
14/06/20 |
ASX - By Stock
|
126
|
49K
|
6
|
|
ASX - By Stock
|
OSL |
Re:
Investor Presentation
|
|
Kelly 42
|
126 |
49K |
4 |
11/06/20 |
11/06/20 |
ASX - By Stock
|
126
|
49K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Investor Presentation
|
|
Kelly 42
|
126 |
49K |
9 |
09/06/20 |
09/06/20 |
ASX - By Stock
|
126
|
49K
|
9
|
|
ASX - By Stock
|
OSL |
Re:
Investor Presentation
|
|
Kelly 42
|
126 |
49K |
4 |
07/06/20 |
07/06/20 |
ASX - By Stock
|
126
|
49K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
Investor Presentation
|
|
Kelly 42
|
126 |
49K |
1 |
07/06/20 |
07/06/20 |
ASX - By Stock
|
126
|
49K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Investor Presentation
|
|
Kelly 42
|
126 |
49K |
9 |
06/06/20 |
06/06/20 |
ASX - By Stock
|
126
|
49K
|
9
|
|
ASX - By Stock
|
OSL |
Re:
Wilson TP 43c
|
|
Kelly 42
|
59 |
26K |
1 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
59
|
26K
|
1
|
|
ASX - By Stock
|
OSL Biotech |
Re:
Finnetwork interview
|
|
Kelly 42
|
3 |
2.1K |
2 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
3
|
2.1K
|
2
|
|
ASX - By Stock
|
OSL Biotech |
Finnetwork interview
|
|
Kelly 42
|
3 |
2.1K |
9 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
3
|
2.1K
|
9
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Becoming a substantial holder
|
|
Kelly 42
|
16 |
7.7K |
1 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
16
|
7.7K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil Entitlement Offer Booklet
|
|
Kelly 42
|
13 |
5.5K |
0 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
13
|
5.5K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil Entitlement Offer Booklet
|
|
Kelly 42
|
13 |
5.5K |
1 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
13
|
5.5K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil Entitlement Offer Booklet
|
|
Kelly 42
|
13 |
5.5K |
0 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
13
|
5.5K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Presentation
|
|
Kelly 42
|
47 |
16K |
5 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
47
|
16K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil Entitlement Offer Booklet
|
|
Kelly 42
|
13 |
5.5K |
7 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
13
|
5.5K
|
7
|
|
ASX - By Stock
|
OSL |
Re:
Ann: OncoSil Entitlement Offer Booklet
|
|
Kelly 42
|
13 |
5.5K |
2 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
13
|
5.5K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Presentation
|
|
Kelly 42
|
47 |
16K |
1 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
47
|
16K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Trading Halt
|
|
Kelly 42
|
56 |
19K |
0 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
56
|
19K
|
0
|
|